Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.

Hermann M, Camici G, Fratton A, Hurlimann D, Tanner FC, Hellermann JP, Fiedler M, Thiery J, Neidhart M, Gay RE, Gay S, Lüscher TF, Ruschitzka F.

Circulation. 2003 Nov 11;108(19):2308-11. Epub 2003 Nov 3.

2.

[COX-2 inhibitor non-steroidal anti-inflammatory drugs, myth or reality?].

Peretz A.

Rev Med Brux. 2001 Sep;22(4):A377-80. Review. French.

PMID:
11680204
3.

Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.

Weir MR, Sperling RS, Reicin A, Gertz BJ.

Am Heart J. 2003 Oct;146(4):591-604. Review.

PMID:
14564311
4.

COX-2-specific inhibitors and the kidney: effect on hypertension and oedema.

Whelton A.

J Hypertens Suppl. 2002 Sep;20(6):S31-5. Review.

PMID:
12683425
5.

Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol).

Graham GG, Graham RI, Day RO.

Curr Pharm Des. 2002;8(12):1063-75. Review.

PMID:
11945151
6.

Selective inhibitors of cyclooxygenase-2: a growing class of anti-inflammatory drugs.

Mardini IA, FitzGerald GA.

Mol Interv. 2001 Apr;1(1):30-8. Review.

PMID:
14993336
7.

Are rofecoxib and celecoxib safer NSAIDS?

[No authors listed]

Drug Ther Bull. 2000 Nov;38(11):81-6. Review.

PMID:
11138599
8.

COX-2 inhibitors. Are they nonsteroidal anti-inflammatory drugs with a better safety profile?

Simon LS.

Gastroenterol Clin North Am. 2001 Dec;30(4):1011-25, viii. Review.

PMID:
11764530
9.

An update on specific COX-2 inhibitors: the COXIBs.

Gupta S, Crofford LJ.

Bull Rheum Dis. 2001;50(1):1-4. Review. No abstract available.

PMID:
12092091
10.

[Specific inhibitors of cyclooxygenase-2 (COX-2): current knowledge and perspectives].

Rioda WT, Nervetti A.

Acta Biomed Ateneo Parmense. 2001;72(3-4):55-64. Review. Italian.

PMID:
11889908
11.

[Specific inhibitors of cyclooxygenase type 2] ].

Tomasová-Studýnková J.

Vnitr Lek. 2002 May;48(5):403-8. Review. Czech.

PMID:
12061207
12.

Rofecoxib.

Hillson JL, Furst DE.

Expert Opin Pharmacother. 2000 Jul;1(5):1053-66. Review.

PMID:
11249495
13.

COX-1 and COX-2 inhibitors.

Hawkey CJ.

Best Pract Res Clin Gastroenterol. 2001 Oct;15(5):801-20. Review.

PMID:
11566042
14.

[Coxibs: cyclooxygenase-2 inhibitors].

Turnheim K.

Wien Klin Wochenschr. 2001 Aug 16;113(15-16):558-65. Review. German.

PMID:
11571832
15.

Effect of cyclooxygenase-2 inhibitors on blood pressure.

Johnson DL, Hisel TM, Phillips BB.

Ann Pharmacother. 2003 Mar;37(3):442-6. Review.

PMID:
12639178
16.
17.

Celecoxib and rofecoxib. The role of COX-2 inhibitors in dental practice.

Moore PA, Hersh EV.

J Am Dent Assoc. 2001 Apr;132(4):451-6. Review.

PMID:
11315375
18.

Selective cyclooxygenase-2 inhibitors for the treatment of arthritis.

Fung HB, Kirschenbaum HL.

Clin Ther. 1999 Jul;21(7):1131-57. Review.

PMID:
10463513
19.

[Coxibs, which real therapeutic advance?: Recent pharmacoepidemiological data].

Montastruc JL, Lapeyre-Mestre M, Gony M, Lugardon S, Bagheri H.

Therapie. 2004 Mar-Apr;59(2):201-5. Review. French.

PMID:
15366126
20.

[The coxibs, third generation anti-inflammatories].

Sternon J.

Rev Med Brux. 2001 Apr;22(2):100-5. Review. French.

PMID:
11388024

Supplemental Content

Support Center